Sign In
to Vote &
Create Storyboards.
 
FDA Gives Nod To Praluent: New Class Of Cholesterol-Lowering Drug Is Pricey Praluent could soon help patients with high cholesterol, as the drug has received FDA approval. However, this new treatment method also comes at a hefty cost.
0
0
0


Storyboard
Print
Share this Article

Recommended

  • {TITLE}
    {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}
  • Create Storyboard